Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y, Watanabe G
Department of Surgery (I), Kanazawa University School of Medicine, 920-8641, Kanazawa, Japan.
Eur J Cardiothorac Surg. 2001 Nov;20(5):1007-11. doi: 10.1016/s1010-7940(01)00954-x.
We retrospectively reviewed nodal status of the patients with peripheral small-sized lung cancer grouped by cell type and tumor size to evaluate the necessity of systematic nodal dissection in this group of patients.
From 1973 to 1998, 1713 patients underwent pulmonary resection for primary lung cancer in Kanazawa University. Among them, 225 patients (13.1%) with peripheral small-sized (2 cm or less) lung cancer underwent lobectomy and systematic nodal dissection were retrospectively reviewed. The maximum diameter of the tumor was measured on formalin-fixed surgical specimens.
The histological types were adenocarcinoma in 170 (75.6%), squamous cell carcinoma in 20 (8.9%), small cell carcinoma in 19 (8.4%) and others in 16 (7.1%). Among 170 adenocarcinoma patients, 38 (22.4%) showed hilar or mediastinal lymph node metastases. No mediastinal lymph node metastasis was encountered in all squamous cell carcinoma (n = 20), adenocarcinoma < or = 1 cm (n = 16), small cell carcinoma < or = 1 cm (n = 4), and adenocarcinoma of Noguchi's classification type A or B (n = 24).
Mediastinal nodal dissection would be unnecessary in the patients with peripheral small-sized lung cancer fulfilling these criteria: (1) squamous cell carcinoma < or = 2 cm; (2) adenocarcinoma < or = 1 cm; (3) localized bronchioloalveolar carcinoma < or = 2 cm without foci of active fibroblastic proliferation in histology (Noguchi's classification type A or B adenocarcinoma); (4) small cell carcinoma < or = 1 cm. Candidates fulfilling above criteria were 28.4% (64/225) of small-sized lung cancer and 10.9% of stage IA patients. The establishment of a universally accepted therapeutic strategy for small-sized lung cancer is indispensable in the clinical spread of various sort of limited resections.
我们通过对周围型小肺癌患者按细胞类型和肿瘤大小分组,回顾性分析其淋巴结状态,以评估该组患者系统性淋巴结清扫的必要性。
1973年至1998年期间,金泽大学有1713例患者因原发性肺癌接受了肺切除术。其中,225例(13.1%)周围型小(2cm或更小)肺癌患者接受了肺叶切除术并进行了系统性淋巴结清扫,对其进行回顾性分析。在福尔马林固定的手术标本上测量肿瘤的最大直径。
组织学类型为腺癌170例(75.6%),鳞状细胞癌20例(8.9%),小细胞癌19例(8.4%),其他16例(7.1%)。在170例腺癌患者中,38例(22.4%)出现肺门或纵隔淋巴结转移。所有鳞状细胞癌(n = 20)、腺癌≤1cm(n = 16)、小细胞癌≤1cm(n = 4)以及Noguchi分类A型或B型腺癌(n = 24)均未发现纵隔淋巴结转移。
符合以下标准的周围型小肺癌患者无需进行纵隔淋巴结清扫:(1)鳞状细胞癌≤2cm;(2)腺癌≤1cm;(3)局限性细支气管肺泡癌≤2cm,组织学上无活跃的纤维母细胞增殖灶(Noguchi分类A型或B型腺癌);(4)小细胞癌≤1cm。符合上述标准的患者占小肺癌患者的28.4%(64/225),占IA期患者的10.9%。在各种有限切除的临床推广中,建立普遍接受的小肺癌治疗策略是必不可少的。